http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200001047-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1999-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2001-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-200001047-A1
titleOfInvention CRYSTAL FORMS (1S) - [1-ALPHA- (2S *, 3R *) - 9-ALPHA] -6,10-DIOXO-N- (2-ETOXI-5-OXOTOTRAHYDRO-3-FURANIL) -9 - [[ (1-IZOHOHINOLIL) CARBONIL] AMINO] -OCTAGYDRO-6H-PYRIDAZINO [1,2-A] [1,2] DIAZEPIN-1-CARBOXAMIDE
abstract The subject of the invention is new crystalline (anhydrous (form A) and hydrated (form B)) forms (1S) - [1-alpha- (2S *, 3R *) -9-alpha] -6,10-dioxo-N- ( 2-ethoxy-5-oxotetragidro-3-furanyl) -9 - [[(1-isoquinolyl) carbonyl] amino] octahydro-6H-pyridazino [1,2-a] [1,2] diazepin-1-carboxamide, method their preparation, their use as a medicine and pharmaceutical compositions containing them. The international application was published together with the international search report.
priorityDate 1998-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18612470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419761398

Total number of triples: 29.